KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Non-Current Debt: 2015-2025

Historic Non-Current Debt for BeOne Medicines (ONC) over the last 10 years, with Sep 2025 value amounting to $832.8 million.

  • BeOne Medicines' Non-Current Debt rose 344.11% to $832.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $832.8 million, marking a year-over-year increase of 344.11%. This contributed to the annual value of $166.5 million for FY2024, which is 15.75% down from last year.
  • As of Q3 2025, BeOne Medicines' Non-Current Debt stood at $832.8 million, which was up 470.02% from $146.1 million recorded in Q2 2025.
  • BeOne Medicines' 5-year Non-Current Debt high stood at $832.8 million for Q3 2025, and its period low was $146.1 million during Q2 2025.
  • Moreover, its 3-year median value for Non-Current Debt was $197.6 million (2023), whereas its average is $244.6 million.
  • Over the last 5 years, BeOne Medicines' Non-Current Debt had its largest YoY gain of 344.11% in 2025, and its largest YoY loss of 21.15% in 2025.
  • Quarterly analysis of 5 years shows BeOne Medicines' Non-Current Debt stood at $202.1 million in 2021, then climbed by 3.48% to $209.1 million in 2022, then fell by 5.51% to $197.6 million in 2023, then fell by 15.75% to $166.5 million in 2024, then surged by 344.11% to $832.8 million in 2025.
  • Its Non-Current Debt was $832.8 million in Q3 2025, compared to $146.1 million in Q2 2025 and $160.2 million in Q1 2025.